LPM 21 mg Pill - white capsule/oblong
Pill with imprint LPM 21 mg is White, Capsule/Oblong and has been identified as Memantine Hydrochloride Extended Release 21 mg. It is supplied by Vitruvias Therapeutics, LLC.
Memantine is used in the treatment of Alzheimer's Disease and belongs to the drug class miscellaneous central nervous system agents. There is no proven risk in humans during pregnancy. Memantine 21 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for LPM 21 mg
Memantine Hydrochloride Extended Release
- Imprint
- LPM 21 mg
- Strength
- 21 mg
- Color
- White (opaque white cap and opaque white body)
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Miscellaneous central nervous system agents
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Vitruvias Therapeutics, LLC
- Manufacturer
- Xiamen LP Pharmaceutical Co., Ltd.
- National Drug Code (NDC)
- 69680-0163
More about memantine
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (90)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: miscellaneous central nervous system agents
- En español
Patient resources
- Memantine drug information
- Memantine (Advanced Reading)
- Memantine Tablets
- Memantine Extended-Release Capsules
- Memantine Solution
Other brands
Professional resources
- Memantine monograph
- Memantine (FDA)
- Memantine ER Tablets (FDA)
- Memantine ER capsules (FDA)
- Memantine Oral Solution (FDA)
- Memantine Tablets (FDA)
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
